Leggett & Platt, Incorporated

LEG

CIK 0000058492 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$939M
↓-11.2% -$118Mvs FY2024 (Q4)
Operating Income
$19M
↓-18.1% -$4Mvs FY2024 (Q4)
Net Income
$19M
↑+988.2% +$17Mvs FY2024 (Q4)
Gross Profit
$168M
↓-4.4% -$8Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
32/100
  • Profitability
    0Insufficient data
  • Liquidity
    87Current Ratio 2.25 (above 1.5 = solid)
  • Leverage
    33D/E 1.33 (under 0.5 = conservative)
  • Efficiency
    71Asset Turnover 1.13x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -11.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project LEG's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -6.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$28.08
Total enterprise IV
$3.92B
Diluted shares
0.14B
Terminal PV
$2.76B (70% of total)
Year-5 FCF
$326M
YearProjected FCFDiscounted PV
+1$289M$263M
+2$298M$246M
+3$307M$231M
+4$316M$216M
+5$326M$202M
Terminal$4.45B$2.76B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$57M
investment in PP&E
Dividends paid (TTM)
$27M
cash returned to holders
Stock buybacks (TTM)
$2M
share count reduction
Stock-based comp (TTM)
$20M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$3.54B
everything owned
Stockholders' equity
$1.02B
shareholder claim
Net debt
$1.31B
LT debt minus cash

Recent performance · 67 quarters

Revenue↓-11.2% -$118M
$939M
Net Income
$25M
Free Cash Flow↑+1.4% +$1M
$102M

Drill down